Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
BMJ Case Reports|February 10, 2021
Transulnar coronary intervention complicated by compartment syndromeMatthijs W L Smits, Rene J van der Schaaf, Jean-Paul Herrman, et al.Journal of Medical Internet Research|March 4, 2014
Attrition and adherence in a WEB-Based Distress Management Program for Implantable Cardioverter defibrillator Patients (WEBCARE): randomized controlled trialMirela Habibović, Pim Cuijpers, Marco Alings, et al.The American Journal of Cardiology|August 8, 2009
Effectiveness and safety of percutaneous coronary sinus-based mitral valve repair in patients with dilated cardiomyopathy (from the AMADEUS trial)Tomasz Siminiak, Uta C Hoppe, Joachim Schofer, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 11, 2015
A prospective, postmarket study with the Mguard Prime Embolic Protection Stent in ST-segment elevation myocardial infarction: the International MGuard Prime Observational Study (IMOS Prime)Giovanni Amoroso, Nicola S Vos, Jan A S Van der Heyden, et al.Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 14, 2017
Web-based distress management for implantable cardioverter defibrillator patients: A randomized controlled trialMirela Habibović, Johan Denollet, Pim Cuijpers, et al.Psychosomatic Medicine|September 30, 2014
E-health to manage distress in patients with an implantable cardioverter-defibrillator: primary results of the WEBCARE trialMirela Habibović, Johan Denollet, Pim Cuijpers, et al.American Heart Journal|January 10, 2021
An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trialNick D Fagel, Giovanni Amoroso, Maarten A Vink, et al.Lancet (London, England)|February 19, 2013
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trialWillem J M Dewilde, Tom Oirbans, Freek W A Verheugt, et al.Pageof 1